World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01079312
Date of registration: 01/03/2010
Primary sponsor: Helsinki University Central Hospital
Public title: Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Scientific title: Patient-controlled Sedation vs Propofol Infusion for ERCP:a Randomized Controlled Study
Date of first enrolment: January 2009
Target sample size: 80
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01079312
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
Finland
Contacts
Name:   Maxim Mazanikov, MD
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Anaesthesiology
Name:   Reino Pöyhiä, Docent
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Anaesthesiology
Name:   Martti Färkilä, Professor
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Gasroenterology
Name:   Jorma Halttunen, Docent
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Surgery
Name:   Leena Kylänpää, Docent
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Surgery
Name:   Marianne Udd, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Surgery
Name:   Outi Lindström, MD
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Surgery
Name:   Pekka Aho, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital,Department of Vascular Surgery
Key inclusion & exclusion criteria

Inclusion Criteria:

- elective ERCP-patients

Exclusion Criteria:

- allergy to propofol or opioid;

- ASA-class (American Society of Anaesthesiology) greater than 3;

- inability to co-operate;

- drugs abuse.



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Endoscopic Retrograde Cholangiopancreatography
Intervention(s)
Device: infusion pump
Device: infusion pump for patient-controlled sedation
Drug: fentanyl
Drug: propofol
Drug: remifentanil hydrochlorid
Drug: sedative mixture
Primary Outcome(s)
patient´s and endoscopist´s satisfaction [Time Frame: one day]
propofol and opioid consumption [Time Frame: one day]
vital signs [Time Frame: one day]
Secondary Outcome(s)
sedation level [Time Frame: one day]
Secondary ID(s)
2008-007968-42
a001c
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history